May 2016 Health Product InfoWatch now available

The goal of the Health Product InfoWatch is to raise awareness and to provide clinically relevant information to healthcare professionals concerning marketed health products and their safety. In some cases, information is intended to stimulate reporting of similar adverse reactions. Each publication includes a monthly recap of health product advisories and summary safety reviews, as well as a growing selection of new health product safety information.

In this issue:

- Monthly recap

- Vaccine Safety Review: Report for July 1, 2015 to September 30, 2015

- Product Monograph Updates: Holkira Pak (ombitasvir/paritaprevir/ritonavir and dasabuvir), Technivie (ombitasvir/paritaprevir/ritonavir)